A detailed history of Strs Ohio transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Strs Ohio holds 9,400 shares of EWTX stock, worth $295,536. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,400
Previous 14,800 36.49%
Holding current value
$295,536
Previous $266,000 6.02%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$15.88 - $29.5 $85,752 - $159,300
-5,400 Reduced 36.49%
9,400 $250,000
Q2 2024

Aug 05, 2024

BUY
$15.08 - $21.23 $33,176 - $46,706
2,200 Added 17.46%
14,800 $266,000
Q1 2024

May 13, 2024

BUY
$9.25 - $19.97 $116,550 - $251,622
12,600 New
12,600 $229,000
Q1 2022

Apr 21, 2022

SELL
$9.1 - $18.97 $26,390 - $55,013
-2,900 Closed
0 $0
Q2 2021

Jul 26, 2021

BUY
$21.33 - $30.25 $61,856 - $87,725
2,900 New
2,900 $61,000

Others Institutions Holding EWTX

About Edgewise Therapeutics, Inc.


  • Ticker EWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,171,700
  • Market Cap $1.99B
  • Description
  • Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...
More about EWTX
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.